Threshold effect of systemic immune-response index on in-stent neoatherosclerosis among patients with drug-eluting stent restenosis
摘要
In-stent neoatherosclerosis (ISNA) is a key mechanism underlying drug-eluting stent in-stent restenosis (DES-ISR), with inflammation playing a critical role. This study aimed to assess the association between the systemic immune-response index (SIRI) and ISNA in DES-ISR patients.
MethodsA retrospective analysis included 212 patients with DES-ISR who underwent coronary angiography and optical coherence tomography (OCT) at least 12 months after stent implantation. SIRI was calculated as (neutrophil count × monocyte count)/lymphocyte count and divided into tertiles. Multivariate logistic regression, smooth curve fitting, threshold effect, and subgroup analyses were performed to evaluate the relationship between SIRI and ISNA risk.
ResultsHigher SIRI tertiles were associated with ISNA and thin-cap fibroatheroma (all P < 0.05). Multivariate analysis identified SIRI as an independent risk factor for ISNA (OR per unit increase 1.23, 95% CI 1.04–1.47, P = 0.018). Smooth curve fitting identified a non-linear association, highlighting a distinct threshold at a SIRI level of 3.95, below which the risk of ISNA rose sharply. Subgroup analysis revealed that the association between SIRI and ISNA risk was largely consistent across most subgroups, with a significant interaction observed only among patients younger than 60 years (OR 1.94, 95% CI 1.23–3.05, P for interaction = 0.010).
ConclusionSIRI is independently and non-linearly associated with the risk of ISNA in DES-ISR patients, with a distinct inflection point observed at a SIRI value of 3.95, below which elevated SIRI levels were significantly correlated with increased ISNA risk. Prospective studies are needed for further validation.